Estimation of Occurrence Peaks of Adverse Events Using Hazard Functions
10.3820/jjpe1996.8.37
- VernacularTitle:ハザード関数を用いた有害事象の好発時期の推定
- Author:
Akira FUKUSHIMA
;
Tadashi HIROOKA
;
Wataru KASHIWAGI
;
Masaki SANO
;
Kunio ITOH
;
Yasuo OHASHI
- Publication Type:Journal Article
- Keywords:
hazard function;
smoothing method;
kernel function;
adverse event
- From:Japanese Journal of Pharmacoepidemiology
2003;8(1):37-44
- CountryJapan
- Language:Japanese
-
Abstract:
Objective : The incidence rate is used frequently in drug safety assessment. The incidence rate of adverse events is defined as the number of patients experiencing a certain adverse event divided by the number of patients administered a drug in spite of duration of administration (observation). In post-marketing surveillance, the duration of administration (observation) typically differs by patient and most of the analyses fail to take into account the differences in duration of administration (observation). Therefore, we investigated the usefulness of hazard functions in a drug safety assessment using the interim results from Clinical Experience Investigation of the oral anticancer drug, TS-1.
Methods : About three thousand patients with gastric cancer were enrolled in this Clinical Experience Investigation. TS-1 was administrated orally twice daily. One course consisted of consecutive administration for 28 days and 14 days rest. Administration was repeated in two courses. Hematological measurements, stomatitis, anorexia, nausea/vomiting, diarrhea, malaise were analyzed. Adverse events were evaluated in accordance with the criteria of the Japan Society for Cancer Therapy, which were established based on criteria established by the WHO. Time to occurrence of an adverse event was calculated from the first day of administration until the adverse event was first observed. Hazard functions were estimated by smoothing methods using kernel functions.
Results : The occurrence of adverse events using smoothed hazard functions had one peak around 10 days in the first course and decreased by administration rest. With the resumption of administration, the occurrence increased again. The occurrence in the second course were less than that of the first course.
Conclusion : The occurrence peaks of adverse events were estimated graphically by smoothed hazard functions. We conclude that hazard functions are useful as an analytical tool in drug safety assessment.
